PubmedID,Title,Publication Date,Non-academic Author(s),Company Affiliation(s),Corresponding Author Email
40087058,"Health-Related Quality of Life in Patients With Relapsed/Refractory Multiple Myeloma Treated With Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone: An Analysis of Patient-Reported Outcomes From the Phase 3 CANDOR Trial.",2025,"Mihaela Talpes, Sachin Patel","Amgen Ltd, Uxbridge, United Kingdom., Amgen Inc., Thousand Oaks, CA.",
40087028,Drug-drug interactions in metastatic hormone-sensitive prostate cancer (mHSPC): practical considerations for treating men with androgen receptor pathway inhibitors and common medications in this stage.,2025,Cristina Ibáñez,"Department of Pharmacy, Institut Català d'Oncologia, Barcelona, Spain.",
